With regard to the risk of adverse outcomes, a cross sectional survey of 3,000 patients in six countries visiting primary care or specialists was conducted to determine if the ACT could accurately predict the GINA classification of "partly controlled or uncontrolled" with its scoring system. A score of <19 correctly predicted partially controlled or uncontrolled asthma 94% of the time overall, and a score of >20 predicted controlled asthma 51% of the time 5 .
A second study sought to test the reliability and validity of the ACT in a longitudinal study of patients new to asthma specialty care. Over 300 patients participated in a baseline test at their 4-week appointment and 12-week follow up with ACT screening. The patients were immediately tested via respiratory spirometry after completing the ACT. The specialist rated the patients asthma control. Responsiveness to changes in asthma control was noted in the ACT score and correlated with the specialist's evaluation. The ACT score of 19 or less was found to be 71% specific and 71% sensitive to identifying uncontrolled asthma 6 .
A third study sought to test the validity of the ACT in a Chinese primary care
setting. Over 400 patients in 15 primary care settings completed the ACT, the Asthma Control Questionnaire and respiratory spirometry testing. The Asthma Control
Questionnaire was used for comparison of scores based on previous studies. ACT screening results were compared with the Asthma Control Questionnaire, the patient rating of control, and specialist's classification of control. Clinical correlation for the ACT scores was strongest with the specialists' rating. Patients were found to rate themselves higher for control than specialists determined. Findings of the study found that the use of the ACT, a reliability 0.861 for all study participants, and discriminative properties would make it applicable for use in primary setting where respiratory spirometry could not be performed 7 .
After 
Results
Screening rates from the retrospective review in 2014 were 55%. Table 1 
Discussion
The Asthma Control Test provides a quick screening tool for evaluating asthma symptom control over the past four weeks. The process of screening the patients enhanced patient education regarding asthma symptoms. This process also provided a score for notification to the provider of symptom control and score trending. The cost to embed the template and train staff was minimal. Prior to this intervention the seven patients who did not present with a complaint of asthma related symptoms may have had missed opportunities for medical management.
Finally, the screening for asthma control is one of the 2015 and 2016 quality metrics that may be included for reporting quality to the Centers for Medicare and Medicaid Services (CMS) under the Physicians Quality Reporting system (i.e. asthma control #398) 8 . This metric can be used in conjunction with other metrics to prevent the 2% negative payment adjustment of 2017 by CMS for failure to report quality metrics.
The use of the ACT in clinical practice was found to be very useful, efficient and effective in identifying patients with poor asthma control. 
